EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
6.1.1.15 | Aneurysm |
27216312 |
Validation of the Simbionix PROcedure Rehearsal Studio sizing module: A comparison of software for endovascular aneurysm repair sizing and planning. |
therapeutic application unassigned |
1 0 |
6.1.1.15 | Carcinogenesis |
27612429 |
EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer. |
causal interaction unassigned |
3 0 |
6.1.1.15 | Coccidiosis |
28867614 |
Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. |
therapeutic application unassigned |
4 0 |
6.1.1.15 | Coinfection |
30521835 |
A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses. |
therapeutic application unassigned |
1 0 |
6.1.1.15 | COVID-19 |
33791697 |
The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection. |
causal interaction ongoing research therapeutic application unassigned |
1 2 4 0 |
6.1.1.15 | Cryptosporidiosis |
28867614 |
Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. |
therapeutic application unassigned |
4 0 |
6.1.1.15 | Dengue |
30521835 |
A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses. |
therapeutic application unassigned |
1 0 |
6.1.1.15 | Diffuse Cerebral Sclerosis of Schilder |
25629079 |
Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome. |
causal interaction unassigned |
1 0 |
6.1.1.15 | Diffuse Cerebral Sclerosis of Schilder |
29915213 |
The genotypic and phenotypic spectrum of PARS2-related infantile-onset encephalopathy. |
causal interaction unassigned |
1 0 |
6.1.1.15 | Gastroenteritis |
25759500 |
Identification of a gamma interferon-activated inhibitor of translation-like RNA motif at the 3' end of the transmissible gastroenteritis coronavirus genome modulating innate immune response. |
unassigned |
0 |